NASDAQ: VTYXVentyx Biosciences Inc Stock Ownership - Who owns Ventyx Biosciences?
Insider buying vs selling
Have Ventyx Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark S. Forman | Chief Medical Officer | 2025-05-15 | 3,000 | $1.03 | $3.09kBuy |
| Roy Gonzales | Senior VP Finance | 2025-05-15 | 1,750 | $1.03 | $1.80kBuy |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2025-04-02 | 1,887 | $1.07 | $2.02kSell |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-27 | 21,119 | $2.36 | $49.84kSell |
| Sheila Gujrathi | Director | 2024-12-23 | 130,000 | $2.31 | $300.56kBuy |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-19 | 13,161 | $2.26 | $29.68kSell |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-10 | 193,557 | $0.20 | $38.71kBuy |
| John Nuss | CHIEF SCIENTIFIC OFFICER | 2024-12-10 | 5,377 | $0.20 | $1.08kBuy |
| Raju Mohan | CEO AND PRESIDENT | 2024-11-25 | 261,752 | $2.01 | $525.07kBuy |
| Raju Mohan | CEO AND PRESIDENT | 2024-11-22 | 238,248 | $1.83 | $435.04kBuy |
VTYX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VTYX insiders and whales buy or sell their stock.
VTYX Shareholders
What type of owners hold Ventyx Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nsv Partners III LP | 33.80% | 24,099,470 | $60.49M | Insider |
| Nsv Investments I LP | 23.69% | 16,892,528 | $42.40M | Insider |
| Somu Subramaniam | 17.49% | 12,471,848 | $31.30M | Insider |
| Point72 Asset Management LP | 8.27% | 5,895,069 | $14.80M | Institution |
| Venbio Global Strategic Fund III LP | 7.03% | 5,011,536 | $12.58M | Insider |
| Affinity Asset Advisors LLC | 6.36% | 4,536,182 | $11.39M | Institution |
| Vanguard Group Inc | 4.43% | 3,162,272 | $7.94M | Institution |
| Tang Capital Management LLC | 4.35% | 3,100,000 | $7.78M | Institution |
| Marshall Wace LLP | 3.36% | 2,396,823 | $6.02M | Institution |
| Raju Mohan | 3.23% | 2,303,540 | $5.78M | Insider |
VTYX vs Biotech Stocks
Ventyx Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.